Ali Khademhosseini

Citation name

Khademhosseini, A.

Affiliation

University of California-Los Angeles (UCLA)

State

CA

Country

USA

Ali Khademhosseini is the Levi Knight Professor of Bioengineering, Chemical Engineering and Radiology and the Founding Director of the Center for Minimally Invasive Therapeutics at University of California-Los Angeles (UCLA). He joined UCLA in Nov. 2017 from Harvard University where he was Professor of Medicine at Harvard Medical School (HMS), and faculty at Harvard-MIT Health Sciences and Technology and the Wyss Institute. At Harvard, he directed the Biomaterials Innovation Research Center (BIRC) a world renown bioengineering initiative comprised of over 100 researchers. He is a leader in applying bioengineering solutions to precision medicine. His large and interdisciplinary group is interested in developing ‘personalized’ solutions that utilize micro- and nanoscale technologies to enable a range of therapies for organ failure, cardiovascular disease and cancer. He has authored >550 journal papers and 60 books/chapters. He is one of the most cited young faculty in the world with >40,000 citations and H-index >100.